Entera Bio Shares Are Trading Higher After the Company Announced Results Showing Significant Systemic Exposure and a Favorable PK Profile in Its Obesity and Metabolic Disorder Studies.
Entera Bio Shares Are Trading Higher After the Company Announced Results Showing Significant Systemic Exposure and a Favorable PK Profile in Its Obesity and Metabolic Disorder Studies.
entrea bio股價上漲，因公司宣佈結果顯示在肥胖和代謝紊亂研究中出現顯著全身曝露和有利的pk特性。
Entera Bio Shares Are Trading Higher After the Company Announced Results Showing Significant Systemic Exposure and a Favorable PK Profile in Its Obesity and Metabolic Disorder Studies.
entrea bio股價上漲，因公司宣佈結果顯示在肥胖和代謝紊亂研究中出現顯著全身曝露和有利的pk特性。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間